Close Menu

stock offering

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific late on Thursday priced its offering of $800 million of senior notes at 99.991 percent of the principal amount.

NEW YORK (GenomeWeb) – Thermo Fisher Scientific today said that it plans to offer dollar-denominated senior notes to repay debt. Additionally it plans to offer euro-denominated senior notes later in the fourth quarter, subject to market conditions.

NEW YORK (GenomeWeb) – Pacific Biosciences on Thursday filed a shelf registration to offer up to $150 million of its securities.

NEW YORK (GenomeWeb) – Nanosphere said after the close of the market Monday that it has closed its public offering of 40 million shares of its common stock at $.50 per share.

NEW YORK (GenomeWeb) – Nanosphere today priced the public offering of 40 million shares of its common stock at $.50 per share.

NEW YORK (GenomeWeb) – WaferGen Biosystems announced today that it has completed an offering of common stock and warrants that brought in gross proceeds of $20 million.

NEW YORK (GenomeWeb) – WaferGen Biosystems today priced a public offering of stock and warrants that is expected to bring in gross proceeds of $20 million.

NEW YORK (GenomeWeb) – NeoGenomics today announced the closing of a public offering that raised $34.6 million in net proceeds.

NEW YORK (GenomeWeb) – NeoGenomics today said that it has priced an offering of 7 million shares of common stock at $4.60 per share.

NEW YORK (GenomeWeb) – Pacific Biosciences raised $20.6 million in net proceeds through the sale of 3 million shares of its common stock during the first half of 2014, the company disclosed in its Form 10-Q filed with the US Securities and Exchange Commission on Monday.

Pages

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.